Your browser doesn't support javascript.
loading
Breaking the mould: challenging the status quo of clinical trial response definitions for invasive fungal diseases-a debate.
Maertens, Johan; Slavin, Monica; Hoenigl, Martin; Thompson, George R; Richardson, Malcolm; Lass-Flörl, Cornelia.
Afiliação
  • Maertens J; University Hospitals Leuven, Department of Haematology and ECMM Excellence Center of Medical Mycology, Campus Gasthuisberg Leuven, Belgium.
  • Slavin M; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
  • Hoenigl M; Division of Infectious Diseases, ECMM Excellence Center of Medical Mycology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Thompson GR; Division of Infectious Diseases, and Departments of Internal Medicine and Medical Microbiology and Immunology, University of California-Davis, Sacramento, CA, USA.
  • Richardson M; Mycology Reference Centre Manchester, ECMM Excellence Center of Medical Mycology, Manchester University NHS Foundation Trust, Manchester, UK.
  • Lass-Flörl C; Christian-Doppler Laboratory for Invasive Fungal Infections, Institute of Hygiene and Medical Microbiology, ECMM Excellence Center of Medical Mycology, Medical University of Innsbruck, Innsbruck, Austria.
J Antimicrob Chemother ; 79(8): 1786-1793, 2024 Aug 01.
Article em En | MEDLINE | ID: mdl-39084680

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto / Infecções Fúngicas Invasivas / Antifúngicos Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto / Infecções Fúngicas Invasivas / Antifúngicos Idioma: En Ano de publicação: 2024 Tipo de documento: Article